# Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response

**Authors:** Michal Stark, Yehuda G. Assaraf

PMC · DOI: 10.7150/ijbs.127929 · International Journal of Biological Sciences · 2026-01-15

## TL;DR

This paper explores how targeting lysosomes can improve cancer treatments by enhancing immune responses and reducing tumor growth.

## Contribution

The paper introduces innovative lysosome modulators and strategies to enhance cancer therapy outcomes.

## Key findings

- Lysosomes can be targeted to reduce autophagy and improve cancer treatment efficacy.
- Modulating lysosomes enhances immune response and inhibits tumor progression.
- Nanoparticle technologies can specifically target tumors to minimize adverse effects.

## Abstract

Cancer is a leading cause of death in Western countries. Apart from surgical resection, the primary treatment modalities chemotherapy and radiotherapy inflict serious side effects, and significantly remodel both tumor metabolism and the tumor microenvironment. This consequently compromises treatment efficacy, resulting in multiple drug resistance, immune evasion and cancer progression. Lysosomes are unique acidic intracellular organelles crucial for maintaining cellular health and homeostasis via degradation of cellular waste. Lysosomes are also required for autophagy, a stress-induced catabolic pathway that is important for cell survival. Autophagy is typically enhanced in tumor cells, as it can confer cyto-protection against the deleterious cytotoxic effects of chemotherapy, and suppress anti-cancer immune response. Owing to their acidic nature and their role in endocytosis, lysosomes can be readily targeted and manipulated, thus attenuating the autophagic flux and improving cancer treatment outcome. Herein we focused on various classic and innovative lysosome modulators, their impact on autophagy, the enhancement of immune response, and consequent inhibition of tumor growth and metastasis. We discuss modalities to minimize adverse effects in cancer patients by either utilizing harmless compounds, achieving synergistic activity with combination therapies, or specifically targeting the tumor by using advanced nanoparticle technologies.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** metastasis (MESH:D009362), death (MESH:D003643), Cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12905581/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12905581/full.md

## References

414 references — full list in the complete paper: https://tomesphere.com/paper/PMC12905581/full.md

---
Source: https://tomesphere.com/paper/PMC12905581